XT
RVMD icon

XTX Topco’s Revolution Medicines RVMD Stock Holding History

XTX Topco’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Buy
+12,925
New +$1.89M 0.03% 928
2026
Q1 		– Sell
-6,939
Closed -$553K – 4305
2025
Q4 		$553K Buy
+6,939
New +$455K 0.01% 1504
2025
Q3 		– Sell
-81,928
Closed -$3.01M – 3166
2025
Q2 		$3.01M Buy
81,928
+26,440
+48% +$1.02M 0.13% 189
2025
Q1 		$1.96M Buy
+55,488
New +$2.25M 0.1% 264
2024
Q3 		– Sell
-23,717
Closed -$920K – 2530
2024
Q2 		$920K Buy
+23,717
New +$886K 0.08% 393
2023
Q4 		– Sell
-19,143
Closed -$530K – 2057
2023
Q3 		$530K Buy
19,143
+6,459
+51% +$192K 0.09% 364
2023
Q2 		$339K Buy
12,684
+2,717
+27% +$66.7K 0.06% 630
2023
Q1 		$216K Sell
9,967
-153
-2% -$3.77K 0.05% 906
2022
Q4 		$241K Buy
+10,120
New +$215K 0.05% 724

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

XTX Topco's RVMD Position: Q2 2026 in Review

XTX Topco opened a new position in Revolution Medicines (RVMD) in Q2 2026: 12,925 shares worth $2.42M. The stake represents 0.03% of the portfolio and ranks #928 among its holdings. This is a return to the name: XTX Topco previously reported a position in RVMD as recently as Q4 2025.

XTX Topco first reported a position in RVMD in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.01M in Q2 2025. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • XTX Topco held 12,925 shares of Revolution Medicines worth $2.42M as of Q2 2026.
  • Revolution Medicines was a new XTX Topco position in Q2 2026.
  • Revolution Medicines made up 0.03% of XTX Topco's portfolio in Q2 2026, its #928 holding.
  • XTX Topco first reported a position in Revolution Medicines in Q4 2022 and has held it in 9 quarters since.
  • XTX Topco's Revolution Medicines position peaked at $3.01M in Q2 2025.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.